Cocaine exposure and developmental outcome from birth to 6 months

Neurotoxicology and Teratology

Volumn 24, Issue 3, 2002, Pages 283-295

  Behnke, Marylou ^a   Eyler, Fonda Davis ^a   Garvan, Cynthia Wilson ^b   Wobie, Kathleen ^a   Hou, Weir ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Developmental outcome; Prenatal cocaine use; Structural equation modeling; Teratogenic and transactional models

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DRUG; ILLICIT DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BIRTH; CAREGIVER; COCAINE DEPENDENCE; COGNITION; CONTROLLED STUDY; DEVELOPMENT; DRUG EFFECT; DRUG USE; ENVIRONMENT; ENVIRONMENTAL FACTOR; FAMILY SIZE; FEMALE; FETUS; GAS CHROMATOGRAPHY; HEAD CIRCUMFERENCE; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MODEL; NEWBORN; PARITY; PATIENT SELECTION; PERINATAL CARE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RISK FACTOR; SOCIAL STATUS; THEORETICAL MODEL; TOBACCO; URINALYSIS;

CHILD DEVELOPMENT; COCAINE-RELATED DISORDERS; CRACK COCAINE; FEMALE; HEAD; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

CANNABIS SATIVA; NICOTIANA TABACUM;

EID: 0036253037     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(02)00191-5     Document Type: Article

References (64)

1. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data
2. Perinatal effects of prenatal drug exposure. Neonatal aspects
3. Incidence and description of structural brain abnormalities in newborns exposed to cocaine
4. The search for congenital malformations in newborns with fetal cocaine exposure
5. Rural pregnant cocaine users: An in-depth sociodemographic comparison
6. Practical issues in structural modeling
7. Maternal and obstetric effects of prenatal drug exposure
8. The relationship of infants' home environments to mental test performance at fifty-four months: A follow-up study
9. Detection of cocaine exposure in the neonate: Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine
10. Cocaine/polydrug use in pregnancy: Two-year follow-up
11. Temporal patterns of cocaine use in pregnancy: Perinatal outcomes
12. Measurement of substance use during pregnancy: Methodologic issues
13. The family support scale: Reliability and validity
14. Convergent and discriminant validity of FACES III: Family adaptability and cohesion
15. Early development of infants exposed to drugs prenatally
16. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment
17. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth
18. Cocaine exposure and developmental outcome birth to three
19. Relative efficacy of biologic specimens and interviews in detection of prenatal cocaine use
20. Growth and pubertal milestones during adolescence in offspring prenatally exposed to cigarettes and marihuana
21. Self-esteem and situational stress: Factors related to sense of competence in new parents
22. Evaluating FACES III and the Circumplex Model: 2440 families
23. Three-year outcome of children exposed prenatally to drugs
24. Prenatal and intrapartum high-risk screening: I. Prediction of the high-risk neonate
25. Prenatal and intrapartum high-risk screening: II. Risk factors reassessed
26. Writing about structural equation models
27. Can test statistics in covariance structure-analysis be trusted
28. Children with in utero cocaine exposure do not differ from control subjects on intelligence testing
29. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy
30. Birth outcomes for infants of drug abusing mothers
31. Prenatal substance exposure: Effects on attention and impulsivity of 6-year olds
32. Regional obstetric anesthesia and newborn behavior: A reanalysis toward synergistic effects
33. Prenatal cocaine exposure and child outcome: What do we really know?
34. Activism and powerful others: Distinctions within the concept of internal-external control
35. Measurement of cocaine and metabolites in urine, meconium, and diapers by gas chromatography/mass spectrometry
36. Relationship between gestational cocaine use and pregnancy outcome: A meta-analysis
37. NIDA survey provides first national data on drug use during pregnancy
38. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth
39. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening
40. Neurodevelopment of adopted children exposed in utero to cocaine
41. Circumplex Model VII: Validation studies and FACES III
42. Circumplex model of family systems VIII: Family assessment and intervention
43. The CES-D scale: A self-report depression scale for research in the general population
44. Prenatal cocaine exposure: Effects on the development of school-age children
45. Maternal and neonatal effects of moderate cocaine use during pregnancy
46. The effects of prenatal cocaine use on neonatal neurobehavioral status
47. Head growth in cocaine-exposed infants: Relationship to neonate hair level
48. Reproductive risk and the continuum of caretaking casualty
49. Parental concepts of development
50. Assessing the impact of life changes: Development of the life experiences survey
51. Neurobehavioral outcomes of cocaine-exposed infants
52. Concepts in teratology and developmental toxicology derived from animal research
53. Cocaine use among pregnant women: Socioeconomic, obstetrical, and psychological issues